Stockreport

Tempo doses first patient with tissue scaffolds in cancer surgery trial [Yahoo! Finance]

COLOPLAST AS SP/ADR  (CLPBY) 
NASDAQ:AMEX Investor Relations: coloplast.com/investor-relations
PDF TT101 is an integrative scaffold with soft tissue regeneration potential. The study is aimed to evaluate the safety of TT01 and gather data on the product's ability to [Read more]